We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
-3.94%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$375M
AUM Growth
-$24.9M
Cap. Flow
-$1.23M
Cap. Flow %
-0.33%
Top 10 Hldgs %
42.13%
Holding
166
New
12
Increased
40
Reduced
71
Closed
8

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$3.3M
2
FMX icon
Fomento Económico Mexicano
FMX
+$3.13M
3
KVUE icon
Kenvue
KVUE
+$2.25M
4
IBM icon
IBM
IBM
+$2.13M
5
ALSN icon
Allison Transmission
ALSN
+$1.32M

Sector Composition

Rank Sector Weight
1 Financials 28.37%
2 Technology 18.88%
3 Healthcare 11.93%
4 Industrials 9.95%
5 Energy 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
76
NVIDIA
NVDA
$5.42T
$713K 0.19%
6,580
-1,100
-14% -$139K
HD icon
77
Home Depot
HD
$355B
$689K 0.18%
1,879
RGLD icon
78
Royal Gold
RGLD
$19.5B
$669K 0.18%
4,092
MCD icon
79
McDonald's
MCD
$195B
$650K 0.17%
2,080
-9
-0.4% -$2.69K
ABT icon
80
Abbott
ABT
$187B
$639K 0.17%
4,815
-24
-0.5% -$3.05K
SBUX icon
81
Starbucks
SBUX
$120B
$612K 0.16%
6,240
-25
-0.4% -$2.58K
PNC icon
82
PNC Financial Services
PNC
$101B
$607K 0.16%
3,451
SHYF
83
DELISTED
The Shyft Group
SHYF
$599K 0.16%
74,021
-46,195
-38% -$496K
PLD icon
84
Prologis
PLD
$133B
$587K 0.16%
5,250
TMO icon
85
Thermo Fisher Scientific
TMO
$220B
$561K 0.15%
1,127
-50
-4% -$27.1K
INVE icon
86
Identive
INVE
$61.9M
$559K 0.15%
175,100
-125,700
-42% -$441K
CYRX icon
87
CryoPort
CYRX
$762M
$539K 0.14%
88,680
-2,050
-2% -$14.2K
BMY icon
88
Bristol-Myers Squibb
BMY
$132B
$535K 0.14%
8,764
-44
-0.5% -$2.56K
LSCC icon
89
Lattice Semiconductor
LSCC
$18.5B
$532K 0.14%
10,145
AMD icon
90
Advanced Micro Devices
AMD
$789B
$529K 0.14%
5,149
ETN icon
91
Eaton
ETN
$174B
$512K 0.14%
1,885
GE icon
92
GE Aerospace
GE
$384B
$502K 0.13%
2,509
+100
+4% +$19.7K
YOU icon
93
Clear Secure
YOU
$5.28B
$492K 0.13%
19,000
QTRX icon
94
Quanterix
QTRX
$190M
$484K 0.13%
74,300
-450
-0.6% -$3.75K
TXO icon
95
TXO Partners LP
TXO
$760M
$479K 0.13%
25,000
BXP icon
96
Boston Properties
BXP
$11.1B
$474K 0.13%
7,059
+41
+0.6% +$2.88K
GTY
97
Getty Realty Corp
GTY
$2.07B
$470K 0.13%
+15,065
New +$462K
IBB icon
98
iShares Biotechnology ETF
IBB
$9.77B
$462K 0.12%
3,615
OKE icon
99
Oneok
OKE
$54.5B
$442K 0.12%
4,450
-200
-4% -$19.9K
TMHC
100
DELISTED
Taylor Morrison
TMHC
$420K 0.11%
7,000

Similar funds

Marathon Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Marathon Capital Management held 166 positions worth $375M, down 6.2% from $400M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Marathon Capital Management's Q1 2025 filing shows 12 new, 40 increased, 71 reduced and 8 closed positions. Its largest new stake was ADMA Biologics: 155,120 shares worth $3.08M. The largest sale was T. Rowe Price, an estimated $3.3M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 31% a quarter earlier, followed by Technology and Healthcare.

  • Marathon Capital Management's largest Q1 2025 buy was ADMA Biologics: 155,120 shares worth $3.08M.
  • Marathon Capital Management added most to Danaher in Q1 2025, an estimated $3.36M increase.
  • Marathon Capital Management's biggest Q1 2025 reduction was T. Rowe Price, cutting an estimated $3.3M.
  • Marathon Capital Management fully exited Fomento Económico Mexicano in Q1 2025, selling an estimated $3.13M.
  • Marathon Capital Management's ten largest holdings make up 42% of its $375M portfolio in Q1 2025.
  • Marathon Capital Management opened 12 new positions and closed 8 in Q1 2025.
  • Marathon Capital Management's portfolio value fell 6.2% quarter-over-quarter to $375M.

Based on Marathon Capital Management's 13F filing for Q1 2025, filed 15 May 2025.